Assessment of Lifestyle, Blood Pressure, Cholesterol and Glycated Hemoglobin in a Specific Population

Arterial Hypertension Clinical Trial

— LB1901  

Official title:

Let's Get to Know Your Health Better? Assessment of Lifestyle, Blood Pressure and Cholesterol in the Population of Employees Libbs Farmacêutica LTDA.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04373863
• Other study ID #: LB1901
• Status: Completed
• Start date: June 29, 2020
• Est. completion date: January 19, 2023

Study information

• Verified date: July 2022
• Source: Libbs Farmacêutica LTDA
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The project Shall we get to know your health better? Lifestyle assessment, blood pressure and cholesterol in the population of Libbs Farmacêutica employeesLTDA.; consists of a study that will bring knowledge and enable quantificationof risk factors related to cardiovascular diseases in this population above mentioned.

Description:

The social relevance of this study is related to the knowledge and quantification of eating habits and lifestyles related to cardiovascular diseases in the population of employees, also referred to in this document as "employees", from Libbs Farmacêutica Ltda. Based on an observation and statistical analysis of the data obtained in this study, internal policies will be promoted that aim to improve eating habits, physical activity and decrease smoking.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2472
• Est. completion date: January 19, 2023
• Est. primary completion date: August 30, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years and older

Eligibility

Inclusion Criteria:

• Being an employee Libbs Farmacêutica Ltda;

Exclusion Criteria:

• not applicable

Related Conditions & MeSH terms

• Arterial Hypertension
• Blood Glucose, High
• Cholesterol; Lipidosis
• Hypertension

Locations

Country	Name	City	State
Brazil	Augusto Theodoro de Figueiredo	São Paulo

Sponsors (1)

Lead Sponsor	Collaborator
Libbs Farmacêutica LTDA

Country where clinical trial is conducted

Brazil, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Descriptive questionnaire	Descriptive information about lifestyle and family history and through exams, blood pressure and serum cholesterol values in the population of Libbs Farmacêutica Ltda employees.	until December 2020
Secondary	Prevalence of hypercholesterolemia and arterial hypertension	Quantify the prevalence of hypercholesterolemia (serum total cholesterol above 200mg / dL - worst case) and hypertension (systolic blood pressure above 140mmHg or diastolic blood pressure above 90mmHg - worst case)	until December 2020
Secondary	Glycated hemoglobin (HbA1c) values	Track the glycated hemoglobin (HbA1c) values of the research participants, in order to know the average blood glucose levels in the last 3 months before the day of the exam and quantify the prevalence of participants who have HbA1c above the value considered normal in literature, which is up to 5.6% (best scenario)	until December 2020
Secondary	Data correlation	Correlate eating habits with socioeconomic characteristics; Correlate the values of serum cholesterol, blood pressure and glycated hemoglobin with eating habits, level of physical activity practiced and prevalence of smoking	until December 2020